细胞色素C对依替米星在大鼠肾脏中蓄积和肾小管毒性的作用

来源 :药物不良反应杂志 | 被引量 : 0次 | 上传用户:tx9yky76
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的探讨细胞色素C对依替米星在大鼠肾脏中的蓄积及其致肾小管毒性的影响。方法将48只SPF级雄性Wistar大鼠按随机数字表分为8组,即溶媒对照组、细胞色素C组、依替米星10 mg/kg组、依替米星10 mg/kg+细胞色素C组、依替米星30 mg/kg组、依替米星30 mg/kg+细胞色素C组、依替米星100 mg/kg组和依替米星100 mg/kg+细胞色素C组,每组6只。溶媒对照组腹腔注射生理盐水;细胞色素C组腹腔注射细胞色素C 100 mg/(kg.d);单用依替米星各组分别腹腔注射依替米星10、30、100 mg/(kg.d);依替米星加用细胞色素C的3组先尾静脉注射细胞色素C 100 mg/(kg.d),约30 min后再分别腹腔注射依替米星10、30、100 mg/(kg.d)。每组大鼠均连续给药3 d,最后一次给药后24 h处死大鼠,摘取双侧肾脏,高效液相色谱法测定肾组织中依替米星蓄积量,脱氧核苷酸末端转移酶介导的缺口末端原位标记法检测肾小管上皮细胞凋亡情况,用CMIAS-Ⅱ医学图像分析系统计算凋亡阳性细胞数密度。结果大鼠肾组织中依替米星浓度如下:依替米星10、30和100 mg/kg组,其浓度分别为(69.3±16.9)、(221.8±66.8)和(305.9±35.5)μg/g;依替米星加细胞色素C组,其浓度分别为(39.0±18.4)(P<0.05)、(121.5±34.2)(P<0.05)和(266.7±43.7)μg/g。大鼠肾小管上皮凋亡细胞数密度如下:依替米星10、30和100 mg/kg组,其密度分别为(266.8±15.4)、(527.7±208.7)和(528.8±145.3)个/mm2;依替米星加细胞色素C组,其密度分别为(97.2±15.4)(P<0.01)、(162.4±36.6)(P<0.01)和(472.5±70.1)个/mm2。结论细胞色素C可抑制依替米星在肾组织中的蓄积进而抑制其所致肾小管毒性。 Objective To investigate the effect of cytochrome C on the accumulation of etimicin in rat kidneys and its renal tubular toxicity. Methods Forty-eight SPF male Wistar rats were randomly divided into 8 groups: vehicle control group, cytochrome C group, etimicin 10 mg / kg group, etimicin 10 mg / kg + cytochrome C Group, etimicin 30 mg / kg group, etimicin 30 mg / kg + cytochrome C group, etimicin 100 mg / kg group and etimicin 100 mg / kg + cytochrome C group, and each group 6 only. The control group was injected intraperitoneally with normal saline. Cytochrome C group was injected intraperitoneally with Cytochrome C 100 mg / (kg · d). Etimicin alone was injected intraperitoneally with 10, 30 and 100 mg / kg . Etirmicin plus Cytochrome C in the three groups of tail vein injection of cytochrome C 100 mg / (kg.d), about 30 min and then were injected intraperitoneally etimicin 10,30,100 mg / (kg.d). Rats in each group were given continuous administration for 3 days and rats were sacrificed 24 hours after the last administration. Both kidneys were harvested and the amount of etimicin accumulation in renal tissues was determined by high performance liquid chromatography. The terminal deoxynucleotidyl transferase Enzyme-mediated nick end labeling in situ was used to detect the apoptosis of renal tubular epithelial cells. The number of apoptotic positive cells was calculated by CMIAS-II medical image analysis system. Results The concentration of etimicin in rat renal tissue was as follows: etimicin at concentrations of 30, 30 and 100 mg / kg were (69.3 ± 16.9), (221.8 ± 66.8) and (305.9 ± 35.5) μg / g and etimicin plus cytochrome C group were 39.0 ± 18.4 (P <0.05), (121.5 ± 34.2) (P <0.05) and (266.7 ± 43.7) μg / g, respectively. The number of apoptotic cells in renal tubular epithelial cells of rats was as follows: The eustachymidine groups were (266.8 ± 15.4), (527.7 ± 208.7) and (528.8 ± 145.3) / mm2 respectively at the 10, 30 and 100 mg / (97.2 ± 15.4) (P <0.01), (162.4 ± 36.6) (P <0.01) and (472.5 ± 70.1) / mm2, respectively. Conclusion Cytochrome C can inhibit the accumulation of etimicin in renal tissue and thus inhibit the renal tubular toxicity.
其他文献
1例29岁男性患者因克罗恩病给予英夫利西单抗300 mg静脉滴注,首次给药后第4天血常规检查:白细胞计数4.63×109/L,中性粒细胞计数2.39×109/L,血红蛋白144 g/L,血小板计数138
1例57岁男性慢性乙型肝炎患者口服阿德福韦10 mg/d治疗,用药约3年发现晨起双足肿胀、疼痛,实验室检查示血清碱性磷酸酶水平升高;用药4年后因双下肢疼痛加重、乏力入首都医科
目的探讨胎儿在子宫内替比夫定暴露后的安全性。方法研究对象为2012年1月1日至11月15日在首都医科大学附属北京地坛医院妇产科进行产前检查并分娩的新生儿。所有新生儿被分为
目的分析替比夫定致肌病和周围神经病的临床特点、相关因素、处置方法及预后。方法筛选北京市药品不良反应监测网络2010年1月1日至2011年6月30日收到的替比夫定严重不良反应
干细胞研究在泌尿外科的应用进展迅速,干细胞研究已用于膀胱替代手术、肾损伤的修复、压力性尿失禁的治疗、男性勃起功能障碍及男性不育的治疗,除压力性尿失禁以外的研究主要
血小板减少症是利奈唑胺所致严重不良反应之一。利奈唑胺所致血小板减少症的危险因素为高龄、女性、治疗周期长、联用3种以上抗生素、基础血小板计数低、肾功能不全等。利奈
炎症反应通过细胞因子的作用参与多种疾病的发生和发展,如缺血性疾病、糖尿病等.Hedgehog(HH)信号通路作为与发育相关的重要信号转导途径,近来被报道与保护细胞免受细胞因子
目的评价2011年北京市疑似预防接种异常反应(AEFI)监测系统运行情况,分析AEFI报告的病例,为进一步改善AEFI监测工作提供依据。方法通过全国AEFI信息管理系统收集2011年北京市
中性粒细胞明胶酶相关脂质运载蛋白(neutrophil gelatinase-associaed lipocalin,NGAL)是一种广泛分布于人体各组织的新型脂钙蛋白,可以调节基质金属蛋白酶9(matrix metatlop
与开放手术相比,腹腔镜手术因其独特的优势在临床上得到越来越广泛地开展,然而由于其特殊的设备及腹腔操作环境,腹腔镜手术是否会促进术后恶性肿瘤细胞种植转移,其治疗恶性肿